Effects of flibanserin on pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy premenopausal women: A two-way crossover randomised study

Trial Profile

Effects of flibanserin on pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy premenopausal women: A two-way crossover randomised study

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2017

At a glance

  • Drugs Flibanserin (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications Female sexual dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Dec 2017 New trial record
    • 30 Nov 2017 Results published in the Clinical Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top